PRESS RELEASE published on 02/05/2025 at 13:15, 9 months 27 days ago CTT Pharma Adds Independent Director With NIH/NSF Experience CTT Pharmaceuticals Holdings, Inc. welcomes Dr. Katherine Cole, a highly accomplished professional with a Ph.D. in Pathology, as an Independent Director. Dr. Cole's extensive experience in cancer research and academia brings valuable insight to CTT Bioavailability Drug Delivery CTT Pharmaceuticals Dr. Katherine Cole Ph.D. In Pathology
BRIEF published on 02/03/2025 at 13:20, 10 months 1 day ago CTT Pharma réduit le nombre d'actions autorisées Actionnaires Structure Du Capital Réduction Des Parts CTT Pharma Liste De Mise À Niveau OTCQB
BRIEF published on 02/03/2025 at 13:20, 10 months 1 day ago CTT Pharma Reduces Authorized Share Count Shareholders Capital Structure Share Reduction CTT Pharma OTCQB Uplist
PRESS RELEASE published on 02/03/2025 at 13:15, 10 months 1 day ago CTT Pharma Reduces Authorized Share Count CTT Pharmaceuticals Holdings, Inc. reduces authorized share count by 150 million shares, demonstrating commitment to optimizing capital structure and value to shareholders. Company to uplist to OTCQB OTCQB Capital Structure CTT Pharmaceuticals Authorized Share Count Micelle Technology
BRIEF published on 01/30/2025 at 13:20, 10 months 5 days ago CTT Pharma sollicite une subvention du NIH pour la recherche sur les bandelettes de nicotine CTT Pharma Université Johns Hopkins Subvention Du NIH Arrêt Du Tabac Bandelettes De Nicotine
BRIEF published on 01/30/2025 at 13:20, 10 months 5 days ago CTT Pharma Pursues NIH Grant for Nicotine Strip Research Smoking Cessation NIH Grant CTT Pharma Nicotine Strips Johns Hopkins
PRESS RELEASE published on 01/30/2025 at 13:15, 10 months 5 days ago CTT Pharma Submits Proposal for NIH Grant CTT Pharmaceuticals Holdings, Inc. submits grant to NIH for further research and commercialization, focusing on dissolvable nicotine strips. Partnership with Johns Hopkins University prioritized Clinical Trials Smoking Cessation NIH Grant CTT Pharmaceuticals Dissolvable Strips
BRIEF published on 01/28/2025 at 13:10, 10 months 7 days ago CTT Pharma and Johns Hopkins University Seek NIH Grant for Smoking Cessation Smoking Cessation NIH Grant CTT Pharma Johns Hopkins University Nicotine Strips
BRIEF published on 01/28/2025 at 13:10, 10 months 7 days ago CTT Pharma et l'Université Johns Hopkins demandent une subvention du NIH pour le sevrage tabagique CTT Pharma Université Johns Hopkins Subvention Du NIH Arrêt Du Tabac Bandelettes De Nicotine
PRESS RELEASE published on 01/28/2025 at 13:05, 10 months 7 days ago Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation CTT Pharma & Johns Hopkins University submit NIH Grant proposal for smoking cessation using CTT technology. CEO Khouri aims to offer innovative nicotine strips. NIH review in Apr 2025 Smoking Cessation NIH Grant CTT Pharma Johns Hopkins University Nicotine Strips
Published on 12/05/2025 at 02:35, 4 hours 56 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 31 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 26 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 31 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 31 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 1 minute ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 40 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 6 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 16 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 16 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 31 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 46 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL